With approval, the HeartMate 3 System offers physicians in Europe the most advanced ventricular assist technology available to support the management of patients with advanced stage heart failure ST.
Abbott has received US Food and Drug Administration (FDA) approval for its Full MagLev HeartMate 3 Left Ventricular Assist System (also known as an LVAD). The HeartMate 3 system provides a new option ...
St. Jude Medical, Inc, a global medical device company, on Tuesday announced approval and launch of the HeartMate 3™ Left Ventricular Assist System (LVAS) in India. "The HeartMate 3 system allows me ...
ABBOTT PARK, Ill., Aug. 29, 2022 /PRNewswire/ -- Abbott today announced new late-breaking data that show its HeartMate 3™ heart pump extends survival of advanced heart failure patients by at least ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results